michigan semaglutide ileus law firm bowel obstruction Food-induced small bowel obstruction observed in a patient with inappropriate use of semaglutide Ozempic Lawsuit Lawyer | Gastrointestinal
Description
o In September 2025, Rybelsus (oral semaglutide) received an EU label update based on the SOUL trial, making it the first and only oral GLP-1 RA with proven cardiovascular benefits, having demonstrated a 14% reduction in cardiovascular death, heart attack, and stroke in high-risk type 2 diabetes patients
These symptoms are generally mild to moderate and tend to diminish over time as the body adjusts to the medication
These medications can be expensive
Improve metabolic health to shift LDL particle distribution toward large, fluffy particles and reduce overall particle number
